Skip to content
Trial Eligibility
Menu

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

NCT06892548

This study is recruiting at 17 US sites in 11 states, according to its ClinicalTrials.gov record last updated .

Summary

This study aims to investigate the combination of BNT324, a B7-H3 antibody-drug conjugate (ADC) with BNT327, a programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF) bispecific antibody, in participants with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NSCLC).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Advanced Lung Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1/2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
BioNTech SE
Last updated on ClinicalTrials.gov
August 26, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Mayo Clinic Arizona · Phoenix, AZ

California · 3

  • Precision NextGen Oncology and Research Center · Beverly Hills, CA
  • Cedars Sinai Medical Center · Los Angeles, CA
  • UCLA - David Geffen School of Medicine · Santa Monica, CA

Colorado · 1

  • University of Colorado Cancer Center · Aurora, CO

Florida · 1

  • Mayo Clinic in Florida · Jacksonville, FL

Iowa · 1

  • University of Iowa Hospitals & Clinics PARENT · Iowa City, IA

Minnesota · 1

  • Mayo Clinic-Rochester · Rochester, MN

New Jersey · 2

  • Regional Cancer Care Associates · Belleville, NJ
  • John Theurer Cancer Center at Hackensack UMC · Hackensack, NJ

New York · 2

  • Icahn School of Medicine at Mount Sinai PRIME · New York, NY
  • Memorial Sloan Kettering Cancer Center (MSKCC) · New York, NY

Ohio · 1

  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center · Cleveland, OH

Texas · 3

  • Texas Oncology - DFW · Dallas, TX
  • MD Anderson Cancer Center · Houston, TX
  • Texas Oncology - Northeast · Tyler, TX

Virginia · 1

  • Virginia Cancer Specialists · Fairfax, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.